-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
5'-Deoxy-5'-isobutylthioadenosine
Category | Herpes simplex Virus (HSV) |
CAS | 35899-54-8 |
Description | 5'-Deoxy-5'-isobutylthioadenosine selectively inhibits spermine synthase. |
Product Information
Synonyms | SIBA; 5'-Isobutylthio-5'-deoxyadenosine; 5'-S-Isobutylthioadenosine; 5'-Deoxy-5'-S-isobutyladenosine; 5'-S-Isobutyl-5'-deoxyadenosine; (2R,3R,4S,5S)-2-(6-Aminopurin-9-yl)-5-(2-methylpropylsulfanylmethyl)oxolane-3,4-diol |
IUPAC Name | (2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-(2-methylpropylsulfanylmethyl)oxolane-3,4-diol |
Molecular Weight | 339.414 |
Molecular Formula | C14H21N5O3S |
Canonical SMILES | CC(C)CSCC1C(C(C(O1)N2C=NC3=C2N=CN=C3N)O)O |
InChI | InChI=1S/C14H21N5O3S/c1-7(2)3-23-4-8-10(20)11(21)14(22-8)19-6-18-9-12(15)16-5-17-13(9)19/h5-8,10-11,14,20-21H,3-4H2,1-2H3,(H2,15,16,17)/t8-,10-,11-,14-/m1/s1 |
InChIKey | JDDUQGRUPLKDNT-IDTAVKCVSA-N |
Purity | 95% |
Solubility | In vitro: 10 mM in DMSO |
Appearance | White Solid |
Application | Antimalarials |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 405 |
Exact Mass | 339.13651072 |
In Vitro | SIBA (0.5 mM; 24-96 h) shows strong anti-proliferative activity against 3LL and RMS-J1 tumour cells SIBA (1 mM; 12, 24 h) reversibly inhibits HSV production in HEp2 cells (infected by HSV-1) SIBA inhibits protein synthesis by 98% after 10 h infection of HEp2 cells (infected by HSV-1) SIBA (1 mM; 8.5 h) inhibits protein synthesis and RNA methylation in HEp2 cells (infected by HSV-1) SIBA (0.5, 1.0 mM; 24, 48 h) inhibits the conversion of putrescine into spermidine and/or spermine and that this inhibition is a reversible one (interferes with polyamine biosynthesis, probably by blocking aminopropyltransferase). |
In Vivo | SIBA (0.5 mM; 24-96 h) shows strong anti-proliferative activity against 3LL and RMS-J1 tumour cells. |
PSA | 144.61000 |
Target | Nucleoside Antimetabolite/Analog; HSV; Parasite |
XLogP3-AA | 1.1 |